Vasocidin

Vasocidin is a brand name of prednisolone/sulfacetamide sodium ophthalmic, approved by the FDA in the following formulation(s):

VASOCIDIN (prednisolone sodium phosphate; sulfacetamide sodium - solution/drops; ophthalmic)

• 
  Manufacturer: NOVARTIS
  
  Approval date: August 26, 1988
  
  Strength(s): EQ 0.23% PHOSPHATE;10% ^[RLD][AT]

Has a generic version of Vasocidin been approved?

Yes. The following products are equivalent to Vasocidin:

SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE (prednisolone sodium phosphate; sulfacetamide sodium solution/drops; ophthalmic)

• 
  Manufacturer: ALCON PHARMS LTD
  
  Approval date: May 27, 1993
  
  Strength(s): EQ 0.23% PHOSPHATE;10% ^[AT]


• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: December 29, 1995
  
  Strength(s): EQ 0.23% PHOSPHATE;10% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vasocidin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Vasocidin.

See also...

• Vasocidin Drops Consumer Information (Wolters Kluwer)
• Vasocidin Consumer Information (Cerner Multum)
• Prednisolone/Sulfacetamide Drops Consumer Information (Wolters Kluwer)
• Prednisolone/Sulfacetamide Ointment Consumer Information (Wolters Kluwer)
• Prednisolone/Sulfacetamide Suspension Consumer Information (Wolters Kluwer)
• Sulfacetamide and prednisolone ophthalmic Consumer Information (Cerner Multum)